Al's Comment:

 This is a new generation of EGFR inhibitor that gets through the blood brain barrier and targets multiple mutations in EGFR.    Worth looking into if your pathology report showed alterations in EGFR!

Posted on: 02/07/2024

For Ivy Center Announces First Patient Treated in Targeted Phase 0/1 Clinical Trial for High-Grade Glioma


Click HERE to return to brain tumor news headlines.

Our privacy / cookie policy has changed.
Click HERE to read it!